Biotech

All Articles

Genentech to shut cancer cells immunology study division

.Genentech will definitely close its cancer immunology research study team, as well as unit mind as ...

Kezar drops strong cyst however to show its worth in stage 1 trial

.Kezar Lifestyle Sciences is actually falling its unpromising stage 1 strong growth medication as th...

Acelyrin drops izokibep, drops 3rd of workers

.In spite of izokibep maintaining its own newfound winning streak in the center, Acelyrin is actuall...

Rivus' stage 2 obesity-related cardiac arrest test hits endpoint

.Rivus Pharmaceuticals has plumped up the leads of its fat-busting, muscle-sparing medicine candidat...

Ovid halts preclinical job, IV system after soticlestat stop working

.Ovid Therapeutics currently showed last month that it was actually trimming back its headcount as t...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston Seaport

.Eli Lilly has actually opened up a $700 million R&ampD center in the Boston ma Seaport, increasing ...

Boundless Bio produces 'modest' cutbacks five months after $100M IPO

.Merely 5 months after safeguarding a $100 thousand IPO, Vast Bio is already laying off some staff m...

Halda's $126M will definitely progress 'keep as well as kill' growth drugs

.The initial stages of oncology R&ampD may not be except interesting new methods, and Halda Rehabs i...

Lykos 'regrets' certainly not divulging research infractions with publisher

.Psychopharmacology has drawn 3 short articles about midstage professional test information evaluati...

Analysts examine Avidity's DMD succeed, showing nuances in records

.Avidity Biosciences satisfied real estate investors along with period 1/2 information in Duchenne m...